Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1303-1311

  Gray, Stacy W ^a   O'Grady, Cristin ^b   Karp, Lauren ^c   Smith, Daniel ^c   Schwartz, J Sanford ^d,e   Hornik, Robert C ^c   Armstrong, Katrina ^d,f  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIRECT TO CONSUMER GENETIC TESTING; FAMILY HISTORY; FEMALE; GENETIC TESTING; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL INFORMATION SYSTEM; MUTATIONAL ANALYSIS; ONLINE SYSTEM; OVARY CANCER; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK INFORMATION; TECHNIQUE;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 66649085192     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0825     Document Type: Article

References (73)

1. Balint J, Shelton W. Regaining the initiative. Forging a new model of the patient-physician relationship. JAMA 1996;275:887-891
2. Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA 1996;275:152-156
3. Rimal RN, Ratzan SC, Arnston P, Freimuth VS. Reconceptualizing the 'patient': health care promotion as increasing citizens' decision-making competencies. Health Commun 1997;9:61-74.
4. Johnson JD. Cancer-related information seeking. Cresskill (NJ): Hampton Press, Inc; 1997.
5. Kaplan RM, Frosch DL. Decision making in medicine and health care. Ann Rev Clin Psychol 2005;1:525-556 (Pubitemid 43843961)
6. Armstrong K, Schwartz JS, Asch DA. Direct sale of sildenafil (Viagra) to consumers over the Internet. N Engl J Med 1999;341:1389-1392 (Pubitemid 29503580)
7. Illes J, Fan E, Koenig BA, Raffin TA, Kann D, Atlas SW. Self-referred whole-body CT imaging: current implications for health care consumers. Radiology 2003;228:346-351 (Pubitemid 36910071)
8. Genetics and Public Policy Center [homepage on the Internet]. Washington, DC: Genetics and Public Policy Center, c2002-08 [updated 2008 Nov 3; cited 2008 Nov 20]. Direct-to-consumer genetic testing companies; [about 1 page]. Available from: http://www. dnapolicy.org/resources/DTCcompanieslist.pdf.
9. Gollust SE, Wilfond BS, Hull SC. Direct-to-consumer sales of genetic services on the Internet. Genet Med 2003;5:332-337 (Pubitemid 36998692)
10. Levitt DM. Let the consumer decide? The regulation of commercial genetic testing. J Med Ethics 2001;27:398-403. (Pubitemid 34030638)
11. Wolfberg AJ. Genes on the Web-direct-to-consumer marketing of genetic testing. N Engl J Med 2006;355:543-545 (Pubitemid 44200646)
12. Williams-Jones B. Where there's a web, there's a way: commercial genetic testing and the Internet. Community Genet 2003;6:46-57. (Pubitemid 36693838)
13. McCabe LL, McCabe ER. Direct-to-consumer genetic testing: access and marketing. Genet Med 2004;6:58-59 (Pubitemid 38175979)
14. Mykitiuk R. Caveat emptor: direct-to-consumer supply and advertising of genetic testing. Clin Invest Med 2004;27:23-32. (Pubitemid 38471384)
15. Hudson K, Javitt G, Burke W, Byers P. ASHG statement on direct-toconsumer genetic testing in the United States. Obstet Gynecol 2007; 110:1392-1395
16. ACMG statement on direct-to-consumer genetic testing. Genet Med 2004;6:60. (Pubitemid 38175980)
17. Siegel R, Palca J. DNA: the machinery behind human beings-Part 1. National Public Radio, All things considered. 2005 Oct 10. Available from: http://www.npr.org/templates/story/story.php?storyId= 4953053. In.
18. Javitt GH, Stanley E, Hudson K. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health. Oklahoma Law Rev 2004;57:251-302.
19. Javitt GH. Policy implications of genetic testing: not just for geneticists anymore. Adv Chronic Kidney Dis 2006;13:178-82.
20. Nutrigenetic Testing: Tests purchased from four web sites mislead consumers. United States Government Accountability Office: GAO- 06-977T: Testimony before the Special Committee on Aging, U.S. Senate. 109th Cong., 2nd Sess. (July 27, 2006). Available from: http:// www.gao.gov/new.items/d06977t. pdf. In.
21. Pollack A. Gene testing questioned by regulators. The New York Times 2008 June 26.
22. Fishbein M, Ajzen I. Belief, attitude, intention, and behavior: an introduction to theory and research. Reading (MA): Addison-Wesley; 1975.
23. Fishbein M, Yzer M. Using theory to design effective health behavior interventions. Communication Theory 2003;13:164-183 (Pubitemid 37084658)
24. Pornpitakpan C. The persuasiveness of source credibility: a critical review of five decades' evidence. J Appl Soc Psychol 2004;34:243-281 (Pubitemid 38318194)
25. US. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005;143:355-361 (Pubitemid 41266608)
26. Myriad Genetics [homepage on the Internet]. Salt Lake City: Myriad Genetics; c1991-2008 [updated 2006 Spring; cited 2008 Nov 20]. BRCA risk calculator and mutation prevalence tables; [about 2 pages]. Available from http://www.myriadtests.com/provider/ brca-mutation-prevalence.htm. In.
27. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-1490 (Pubitemid 34260526)
28. DNAdirect [homepage on the Internet]. San Francisco. DNAdirect; c2003-08 [updated 2008; cited 2005 Oct 03]: Available from: http:// www.dnadirect.com/.
29. Miller SM, Shoda Y, Hurley K. Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull 1996;119:70-94.
30. Roche PA, Annas GJ. DNA testing, banking, and genetic privacy. N Engl J Med 2006;355:545-546 (Pubitemid 44200647)
31. Gollust SE, Hull SC, Wilfond BS. Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA 2002;288:1762-1767
32. Federal Trade Commission, Bureau of Consumer Protection, Division of Consumer and Business Education [homepage on the Internet]. Washington DC: Federal Trade Commission; c1914-2008 [updated 2008 Mar 29; cited 2006 Jul]. FTC facts for consumers, at home genetic tests: a healthy dose of skepticism may be the best prescription. Available from: http://www.ftc.gov/bcp/edu/pubs/ consumer/health/hea02.htm. In.
33. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-267
34. Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS. Interest in BRCA1/2 testing in a primary care population. Prev Med 2002;34: 590-595 (Pubitemid 34971660)
35. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005;293:1729-1736 (Pubitemid 40491298)
36. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991;32:35-42.
37. Shea JA, Micco E, Dean LT, McMurphy S, Schwartz JS, Armstrong K. Development of a revised Health Care System Distrust scale. J Gen Intern Med 2008;23:727-732
38. Jallinoja P, Hakonen A, Aro AR, et al. Attitudes towards genetic testing: analysis of contradictions. Soc Sci Med 1998;46:1367-1374 (Pubitemid 28245931)
39. Ware JE, Jr., Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995;33: AS264-79.
40. Mossey JM, Shapiro E. Self-rated health: a predictor of mortality among the elderly. Am J Public Health 1982;72:800-808
41. Idler EL, Angel RJ. Self-rated health and mortality in the NHANES-I Epidemiologic Follow-up Study. Am J Public Health 1990;80:446-452 (Pubitemid 20105952)
42. Connelly JE, Philbrick JT, Smith GR, Jr., Kaiser DL, Wymer A. Health perceptions of primary care patients and the influence on health care utilization. Med Care 1989;27:S99-109.
43. Human Genetic Commission [homepage on the Internet]. London: Human Genetics Commission; c1999-2008 [updated 2008 Nov; cited 2008 Nov 20]. YouGov: Public attitudes to genetic testing, a quantitative study for the Human Genetics Commission, 27th December 2002 to 5th January 2003. Available from: http://www. hgc.gov.uk/UploadDocs/DocPub/Document/evidence-yougov. pdf. In.
44. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-1462
45. Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kincohort study in Ontario, Canada. J Natl Cancer Inst 2006;98: 1694-1706 (Pubitemid 44942707)
46. Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annu Rev Genet 1998;32:95-121. (Pubitemid 29045309)
47. Schwartz MD, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson L. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women. Cancer 2001;92:932-940 (Pubitemid 32783083)
48. Green MJ, Biesecker BB, McInerney AM, Mauger D, Fost N. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. Am J Med Genet 2001; 103:16-23. (Pubitemid 32803093)
49. Green MJ, Peterson SK, Baker MW, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA 2004;292:442-452 (Pubitemid 38988953)
50. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996;275:1885-1892
51. Botkin JR, Smith KR, Croyle RT, et al. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A 2003;118A:201-209 (Pubitemid 37063927)
52. Biesecker BB, Ishibe N, Hadley DW, et al. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 2000;93: 257-263 (Pubitemid 30497442)
53. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.[comment]. N Engl J Med 2002;346:1616-1622 (Pubitemid 34755669)
54. Rebbeck TR, Levin AM, Eisen A, et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999;91:1475-1479 (Pubitemid 29424552)
55. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingooophorectomy in women with a BRCA1 or BRCA2 mutation.[comment]. N Engl J Med 2002;346:1609-1615 (Pubitemid 34755668)
56. Shih HA, Couch FJ, Nathanson KL, et al. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 2002;20:994-999 (Pubitemid 34141843)
57. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.[comment]. N Engl J Med 2001;345: 159-164 (Pubitemid 32662123)
58. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.[comment]. N Engl J Med 1999;340:77-84. (Pubitemid 29054841)
59. Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 2005;23:7491-7496 (Pubitemid 46291812)
60. Hall MJ, Olopade OI. Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol 2006;24:2197-2203 (Pubitemid 46630692)
61. Lerman C, Shields AE. Genetic testing for cancer susceptibility: the promise and the pitfalls. Nat Rev Cancer 2004;4:235-241 (Pubitemid 38337503)
62. Vadaparampil ST, Wideroff L, Breen N, Trapido E. The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2006;15: 618-623
63. Matthews AK, Cummings S, Thompson S, Wohl V, List M, Olopade O. Genetic testing of African-Americans for susceptibility to inherited cancers: use of focus groups to determine factors contributing to participation. J Psychosoc Oncol 2000;18:1-19. (Pubitemid 30666496)
64. Hughes C, Fasaye GA, LaSalle VH, Finch C. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 2003;51: 107-114 (Pubitemid 37311327)
65. Sankar P, Wolpe PR, Jones NL, Cho M. How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States. Community Genet 2006;9:78-86.
66. Kinmonth AL, Reinhard J, Bobrow M, Pauker S. The new genetics. Implications for clinical services in Britain and the United States. BMJ 1998;316:767-770
67. Watson EK, Shickle D, Qureshi N, Emery J, Austoker J. The 'new genetics' and primary care: GPs' views on their role and their educational needs. Fam Pract 1999;16:420-425 (Pubitemid 29410765)
68. Hayflick SJ, Eiff MP. Role of primary care providers in the delivery of genetics services. Community Genet 1998;1:18-22.
69. Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med 2003;5:70-76 (Pubitemid 36992615)
70. Freedman AN, Wideroff L, Olson L, et al. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A 2003;120:63-71. (Pubitemid 37063834)
71. Burke W, Emery J. Genetics education for primary-care providers. Nat Rev Genet 2002;3:561-566 (Pubitemid 34746881)
72. Emery J, Watson E, Rose P, Andermann A. A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract 1999;16:426-445 (Pubitemid 29410766)
73. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 2005;42:749-755 (Pubitemid 41475249)